DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

June 28, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Advanced or Metastatic Solid Tumors
Interventions
DRUG

DCSZ11

A monoclonal antibody that binds to CD93, DCSZ11 will be administered as a single intravenous (IV) infusion on Day 1 in each 21-day cycle.

DRUG

Pembrolizumab

Pembrolizumab injection

DRUG

Doxorubicin

1b SOC Cohort 1: Doxorubicin combination in soft tissue sarcoma

DRUG

Tebentafusp

1b SOC Cohort 2: Tebentafusp combination in uveal melanoma

Trial Locations (35)

704

RECRUITING

National Cheng Kung University Hospital, Tainan City

807

RECRUITING

Kaohsiung Medical University Chung-ho Memorial Hospital, Kaohsiung City

2010

RECRUITING

St Vincent's Hospital, Sydney

2031

RECRUITING

Scientia Clinical Research, Randwick

3144

COMPLETED

Cabrini Hospital, Malvern

3168

RECRUITING

Monash Health, Clayton

4556

WITHDRAWN

University of Sunshine Coast, Buderim

5011

RECRUITING

The Queen Elizabeth Hospital (TQEH), Woodville South

5042

RECRUITING

Southern Oncology Clinical Research Unit (SOCRU), Bedford Park

6009

RECRUITING

Linear Clinical Research Limited, Nedlands

10461

RECRUITING

MonteFiore, The Bronx

11217

RECRUITING

Taipei Veterans General Hospital, Taipei

13496

RECRUITING

Cha University Bundang Medical Center, Gyeonggi-do

21231

RECRUITING

John Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore

32224

RECRUITING

Mayo Clinic, Jacksonville

33136

RECRUITING

University of Miami, Miami

35294

RECRUITING

University of Alabama, Birmingham

37203

RECRUITING

SCRI Oncology Partners, Nashville

43210

RECRUITING

Ohio State University, Columbus

48108

RECRUITING

Inje University Haeundae Paik Hospital, Busan

49201

RECRUITING

Dong-a University Hospital, Busan

55905

RECRUITING

Mayo Clinic, Rochester

80045

RECRUITING

University of Colorado, Aurora

80218

RECRUITING

Sarah Cannon Research Institute Denver Healthone, Denver

85054

RECRUITING

Mayo Clinic, Phoenix

85258

RECRUITING

HonorHealth, Scottsdale

06519

RECRUITING

Yale Cancer Center, New Haven

02215

COMPLETED

Dana Farber Cancer Institute, Boston

QLD4810

RECRUITING

Townsville Hospital, Douglas

NSW2170

COMPLETED

Liverpool Hospital, Liverpool

QLD4101

RECRUITING

Mater Misericordiae Health Services Brisbane Ltd, South Brisbane

Unknown

WITHDRAWN

Sydney Adventist Hospital, Wahroonga

WITHDRAWN

Asan Medical Center, Seoul

RECRUITING

National Taiwan University Hospital, Taipei

03722

RECRUITING

Severance Hospital, Yonsei University Health System, Seoul

Sponsors
All Listed Sponsors
lead

DynamiCure Biotechnology

INDUSTRY